Stockreport

Nymox Announces New Peer Review Article on Fexapotide Pharmaco-Ablation Experimental Studies Published in Research and Reports in Urology

Nymox Pharmaceutical Corporation  (NYMX) 
US:NASDAQ Investor Relations: nymox.com/default.action?itemid=3
PDF HASBROUCK HEIGHTS, N.J., Jan. 06, 2020 (GLOBE NEWSWIRE) -- Nymox Pharmaceutical Corporation (NASDAQ: NYMX) is pleased to report a new peer review research report has b [Read more]